<DOC>
	<DOC>NCT00514865</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of ONO-2333Ms in patients with Recurrent Major Depressive Disorder</brief_summary>
	<brief_title>Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Diagnosed with recurrent major depressive disorder Patients with treatment resistance for depression History of alcohol abuse/dependence, substance abuse/dependence within 6 months Has clinically significant unstable medical condition Has significant risk of suicide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>ONO-2333Ms</keyword>
	<keyword>Major Depressive Disorder</keyword>
</DOC>